I
Indegene
Helps global healthcare organizations address complex challenges by seamlessly integrating analytics and technology
At a glance
- Founded
- 1998
- Headquarters
- Woodbridge Township, United States
- Listing
- IPO 2024
- Sector
- Health Tech & Medtech
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Research & analysis
Latest news
Press, funding announcements and product moves mentioning Indegene.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- TGThe Carlyle Group
- BCBrighton Park Capital
Source: Dealroom Talent Intelligence.
Alumni founders
Former Indegene employees who went on to found companies, sorted by Dealroom signal score.
Vinayak -India
DODocereeEst. 2018
Daleep ManhasUnited States
Manish GuptaUnited States
PRPrognosEst. 2010
Destry SulkesUnited States
Rakesh ShivranIndiaGlobal footprint
team presence
across markets
Investments and acquisitions
Disclosed deals where Indegene was the backer or acquirer, 2006–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
9 deals across Indegene's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Indegene's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Indegene on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Indegene on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.